ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,549Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 1006

$2.03M Total Retail Price of All Prescriptions

Rank: 7 out of 1006

582 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
90% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 582 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

5% of this provider’s 582 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 25,457 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$66 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

52 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LISINOPRIL 1,679 1,371 1 3
SIMVASTATIN 1,255 1,017 2 1
OMEPRAZOLE 1,014 871 3 9
WARFARIN SODIUM 945 813 4 8
AMLODIPINE BESYLATE 896 766 5 4
FUROSEMIDE 880 763 6 6
LEVOTHYROXINE SODIUM 838 737 7 2
ATORVASTATIN CALCIUM 683 563 8 5
TRAZODONE HCL 585 528 9 21
METOPROLOL TARTRATE 561 495 10 7
HYDROCHLOROTHIAZIDE 544 459 11 11
METFORMIN HCL 434 336 12 10
MIRTAZAPINE 428 416 13 26
DONEPEZIL HCL 419 419 14 17
GABAPENTIN 392 324 15 20
LANTUS 389 307 16 43
TRAMADOL HCL 384 344 17 35
CYMBALTA 379 328 18 41
TAMSULOSIN HCL 341 294 19 23
CARVEDILOL 341 290 19 36
NOVOLOG 335 267 21 94
MELOXICAM 327 274 22 67
NAMENDA 326 312 23 34
JANUVIA 319 291 24 49
ZETIA 294 245 25 51
RISPERIDONE 283 215 26 40
ADVAIR DISKUS 278 216 27 37
SERTRALINE HCL 276 231 28 19
ZOLPIDEM TARTRATE 270 215 29 14
QUETIAPINE FUMARATE 264 239 30 45
PREDNISONE 261 217 31 33
CRESTOR 258 215 32 18
METOPROLOL SUCCINATE 258 219 32 12
DIOVAN 241 218 34 16
ACTOS 241 238 34 89
ATENOLOL 219 184 36 13
CITALOPRAM HBR 217 196 37 24
NEXIUM 209 138 38 28
LOSARTAN POTASSIUM 204 174 39 22
PAROXETINE HCL 197 144 40 62
IPRATROPIUM-ALBUTEROL 195 191 41 73
POTASSIUM CHLORIDE 183 173 42 30
ESCITALOPRAM OXALATE 182 142 43 27
DIVALPROEX SODIUM 178 142 44 53
GLIPIZIDE ER 172 151 45 108
LISINOPRIL-HYDROCHLOROTHIAZIDE 170 142 46 38
CLOPIDOGREL 169 129 47 46
HUMALOG 166 121 48 116
METHOCARBAMOL 150 90 R 49 225
SPIRIVA 144 126 50 48
FINASTERIDE 130 118 51 76
ISOSORBIDE MONONITRATE ER 126 109 52 59
ACTOPLUS MET 124 101 53 271
PIOGLITAZONE HCL 118 112 R 54 223
OXYCODONE-ACETAMINOPHEN 117 54 S2 55 57
CARBIDOPA-LEVODOPA 117 117 55 80
HYDROXYZINE HCL 116 82 R 57 189
LEVETIRACETAM 114 58 58 72
OXYBUTYNIN CHLORIDE ER 113 113 59 92
PLAVIX 110 87 60 61
LANTUS SOLOSTAR 107 51 61 93
OLANZAPINE 107 100 61 68
DOXAZOSIN MESYLATE 106 106 63 87
DIGOXIN 105 100 64 52
ALENDRONATE SODIUM 103 82 65 29
METOCLOPRAMIDE HCL 103 102 65 134
GLIPIZIDE 102 88 67 69
TOPIRAMATE 100 53 68 162
LIPITOR 100 70 68 47
PANTOPRAZOLE SODIUM 96 80 70 32
SEROQUEL 93 80 71 97
RANITIDINE HCL 92 74 72 63
HYDROCODONE-ACETAMINOPHEN 92 57 S3 72 25
HYDRALAZINE HCL 89 75 74 100
PROAIR HFA 83 51 75 64
PHENYTOIN SODIUM EXTENDED 83 70 75 149
TRAVATAN Z 82 82 77 131
GENERLAC 81 70 78 140
AZITHROMYCIN 80 60 79 39
GLIMEPIRIDE 80 80 79 50
DILTIAZEM 24HR CD 80 69 79 88
ALLOPURINOL 80 65 79 31
KLOR-CON M20 80 54 79 70
OXYCONTIN 80 36 S2 79 98
ROPINIROLE HCL 78 64 85 154
SPIRONOLACTONE 78 64 85 71
HYDROMORPHONE HCL 77 74 S2 87 153
PEN NEEDLE 75 42 88 128
CIPROFLOXACIN HCL 75 61 88 75
FLUTICASONE PROPIONATE 73 47 90 55
KETOCONAZOLE 72 68 91 206
INSULIN SYRINGE 71 53 92 122
FLUOCINONIDE 70 54 93 291
SINGULAIR 67 46 94 82
VYTORIN 67 54 94 145
BACLOFEN 67 53 94 95
DICLOFENAC SODIUM 66 34 97 213
GLIPIZIDE XL 66 66 97 175
LATANOPROST 65 65 99 192
VENTOLIN HFA 62 51 100 161
CELEBREX 61 51 101 90
BENZTROPINE MESYLATE 61 36 R 101 106
DIOVAN HCT 61 53 101 60
BUDESONIDE 60 60 104 245
TIZANIDINE HCL 59 40 105 179
FLUOXETINE HCL 58 47 106 85
PRAVASTATIN SODIUM 56 55 107 15
OXYBUTYNIN CHLORIDE 56 47 107 197
LIDODERM 55 49 109 66
NOVOLOG FLEXPEN 54 32 110 190
TIMOLOL MALEATE 54 54 110 261
LOSARTAN-HYDROCHLOROTHIAZIDE 53 38 112 81
COLCRYS 53 45 112 186
VERAPAMIL ER 53 53 112 116
ENULOSE 52 45 115 201
CLONIDINE HCL 51 51 116 165
AMIODARONE HCL 51 51 116 168
MORPHINE SULFATE ER 50 38 S2 118 142
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 20, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.